Factor X/Xa Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIPA143061-Each-of-1 | In Stock | ₹ 25,943.50 |
PIPA143061 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 25,943.50
GST (18%): ₹ 4,669.83
Total Price: ₹ 30,613.33
Antigen
Factor X/Xa
Classification
Polyclonal
Conjugate
Unconjugated
Gene
F10
Gene Alias
Activated factor Xa heavy chain; blood coagulation factor X; Cf10; coagulation factor 10; coagulation factor X; coagulation factor X protein; F10; Factor X heavy chain; Factor X light chain; factor Xa; FX; FXA; prothrombinase; stuart factor; Stuart-Prower factor; Unknown (protein for IMAGE:8121240); unnamed protein product
Host Species
Sheep
Purification Method
Ammonium sulfate precipitation, Ion-exchange chromatography
Regulatory Status
RUO
Gene ID (Entrez)
14058
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Form
Liquid
Applications
ELISA, Western Blot
Concentration
25 mg/mL
Formulation
50% water with 50% glycerol and no preservative
Gene Accession No.
O88947
Gene Symbols
F10
Immunogen
Murine Factor X.
Quantity
1 mg
Primary or Secondary
Primary
Target Species
Mouse
Product Type
Antibody
Isotype
IgG
Related Products
Description
- PA1-43061 detects Factor X in mouse samples
- PA1-43061 has successfully been used in Western blot and ELISA applications
- PA1-43061 was derived from mouse factor X
- Factor X undergoes multiple processing steps before its preproprotein is converted to a mature two-chain form by the excision of the tripeptide RKR
- Two chains of the factor are held together by 1 or more disulfide bonds; the light chain contains 2 EGF-like domains, while the heavy chain contains the catalytic domain which is structurally homologous to those of the other hemostatic serine proteases
- The mature factor is activated by the cleavage of the activation peptide by factor IXa (in the intrisic pathway), or by factor VIIa (in the extrinsic pathway)
- The activated factor then converts prothrombin to thrombin in the presence of factor Va, Ca+2, and phospholipid during blood clotting
- Mutations of this gene result in factor X deficiency, a hemorrhagic condition of variable severity.